ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Henschke Responds To Questions from The New York Times

April 29, 2011

Komen Deal With KFC Yields Buckets Of Discord

April 23, 2010

Phase II ThermoDox Trial Demonstrates Positive Response

August 29, 2014

AACR honors Five With Awards Next Month

April 2, 1993

President Clinton Seeks 8% Increase For NCI; Most Institute Take Cuts In $10 Bll. NIH Budget

April 16, 1993

In Brief: Greenwald Named Director, NCI Prevention; Wells Directs American College Of Surgeons

June 19, 1998